Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Reviva Pharmaceuticals Holdings Inc (NASDAQ:RVPH) is trading higher with around 60k in session volume.
- Maxim initiated coverage of Reviva with a Buy rating and $10 price target, equivalent to an upside of around 140%.
- The company is developing its lead asset, RP5063 (brilaroxazine), to treat schizophrenia and respiratory indications.
- Analyst Jason McCarthy tells in a research note that RP5063 features a multimodal mechanism of action, which is "more completely" addressing the mix of positive, negative, and cognitive symptoms associated with schizophrenia.
- In April, RP5063 showed positive action in the schizophrenia trial that met its primary endpoint of disease severity versus placebo.
- Price Action: RVPH shares are up 9.92% at $4.21 during the market session on the last check Monday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!